2008
DOI: 10.1007/s11695-008-9587-7
|View full text |Cite
|
Sign up to set email alerts
|

Ursodeoxycholic Acid in the Prevention of Gallstone Formation after Bariatric Surgery: A Meta-analysis

Abstract: UDCA can prevent gallstone formation after bariatric surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
53
0
7

Year Published

2009
2009
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 128 publications
(63 citation statements)
references
References 11 publications
(35 reference statements)
3
53
0
7
Order By: Relevance
“…It also acts by decreasing the biliary nidus forming factors by reduction of glycoprotein secretion and dissolution of gallstones (11). A meta-analysis concluded that the daily administration of 500 mg UDCA is an effective method of preventing gallstone formation after bariatric surgery (11).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It also acts by decreasing the biliary nidus forming factors by reduction of glycoprotein secretion and dissolution of gallstones (11). A meta-analysis concluded that the daily administration of 500 mg UDCA is an effective method of preventing gallstone formation after bariatric surgery (11).…”
Section: Discussionmentioning
confidence: 99%
“…These are performing cholecystectomy simultaneously with gastric bypass regardless of the presence of gallstones (prophylactic approach) (6)(7)(8), performing simultaneous cholecystectomy in all patients with gallstones (elective or selective approach) (9, 10), performing simultaneous cholecystectomy in patients with symptomatic gallstones, and methods in which prophylactic ursodeoxycholic acid (UDCA) therapy was initiated or not until development of symptoms (conventional approach) (5,11).…”
Section: Introductionmentioning
confidence: 99%
“…This pattern of incidence (higher in the phase of greater weight loss) has motivated several surgeons to use ursodeoxycholic acid in the first 6 postoperative months [14][15][16]. This drug is a bile acid that prevents biliary lithiasis by decreasing cholesterol and mucin concentration, increasing bile acid concentration, decreasing bile saturation, and enhancing gallbladder emptying [16,33]. Various risk factors for formation of gallstones are known, in the general population, such as age, obesity, female gender, parity, positive family history, use of contraceptives, etc.…”
Section: Open Access Ssmentioning
confidence: 99%
“…53) UDCA, which is litholytic and hydrophilic, greatly decreases the risk of cholesterol gallstone formation (<10%) and of gallstones be-coming symptomatic, 58) following rapid weight loss. 58,59) A meta-analysis of 5 randomized controlled trials including 521 patients (322 taking UDCA and 199 taking a placebo) concluded that UDCA 300-1,200 mg/d effectively prevents gallstone formation after bariatric surgery, 59) reducing the incidence from 32% to 2%, 60) with no severe side effects.…”
Section: ) Obese Patients Undergoing Rapid Weight Lossmentioning
confidence: 99%